Kirsten Bibbins-Domingo (@kbibbinsdomingo) 's Twitter Profile
Kirsten Bibbins-Domingo

@kbibbinsdomingo

Editor in Chief @JAMA_current & the @JAMANetwork | Professor @UCSF | scientist, physician, teacher | she/her | views mine

ID: 178316031

linkhttp://profiles.ucsf.edu/kirsten.bibbins-domingo calendar_today14-08-2010 12:40:49

23,23K Tweet

13,13K Followers

604 Following

Peer Review Congress #PRC10 (@peerrevcongress) 's Twitter Profile Photo

The PRC10 Abstract submission site is now open! Submit by Jan 31, 2025 at abstracts.peerreviewcongress.org Abstracts that report new research & findings w generalizable results are given priority. Learn more at peerreviewcongress.org JAMA Network The BMJ METRICStanford

JAMA (@jama_current) 's Twitter Profile Photo

JAMA Editor in Chief Kirsten Bibbins-Domingo and Deputy Editor Preeti Malani give a summary of articles published from January 11-17. Listen on AMA Ed Hub™. ja.ma/3PMjhUN

JAMA Editor in Chief Kirsten Bibbins-Domingo and Deputy Editor Preeti Malani give a summary of articles published from January 11-17. 

Listen on <a href="/AMAEdHub/">AMA Ed Hub™</a>. 

ja.ma/3PMjhUN
Jay Piccirillo, MD (@piccirillojay) 's Twitter Profile Photo

We look forward to welcoming Kirsten Bibbins-Domingo for medicine grand rounds on Thursday, January 30th WashU Medicine. Dr. Bibbins-Domingo is the Editor in Chief of JAMA and Professor of Medicine at UCSF. The title of her talk is “Trust in Medical Publishing.”

We look forward to welcoming <a href="/KBibbinsDomingo/">Kirsten Bibbins-Domingo</a> for medicine grand rounds on Thursday, January 30th <a href="/washumedicine/">WashU Medicine</a>. Dr. Bibbins-Domingo is the Editor in Chief of <a href="/JAMA_current/">JAMA</a> and Professor of Medicine at UCSF. The title of her talk is “Trust in Medical Publishing.”
JAMA (@jama_current) 's Twitter Profile Photo

Authors, editors, reviewers, and other potential users should use CONSORT 2025 when writing and evaluating manuscripts of randomized trials to ensure that trial reports are clear and transparent. Learn more in this Special Communication. ja.ma/4ilAvEx

Authors, editors, reviewers, and other potential users should use CONSORT 2025 when writing and evaluating manuscripts of randomized trials to ensure that trial reports are clear and transparent. 

Learn more in this Special Communication. ja.ma/4ilAvEx
Kirsten Bibbins-Domingo (@kbibbinsdomingo) 's Twitter Profile Photo

Celebrating the successful conclusion of another JAMA Week! 🎉 Proud to work alongside this committed team of editors, publishers, staff, board members, & advisors united in the mission of advancing the health of patients & the public through the dissemination of science

Celebrating the successful conclusion of another JAMA Week! 🎉 Proud to work alongside this committed team of editors, publishers, staff, board members, &amp; advisors united in the mission of advancing the health of patients &amp; the public through the dissemination of science
Kirsten Bibbins-Domingo (@kbibbinsdomingo) 's Twitter Profile Photo

Pleasure to meet leaders of the Rwanda Journal of Medicine and Health Sciences- Prof Jansen, EiC, Prof Njunwa, Deputy EiC, & Mr Nisingizwe, Managing Editor JAMA is proud to participate in the African Journal Partnership Program ajpp-online.org

Pleasure to meet leaders of the Rwanda Journal of Medicine and Health Sciences- Prof Jansen, EiC, Prof Njunwa, Deputy EiC, &amp; Mr Nisingizwe, Managing Editor

JAMA is proud to participate in the African Journal Partnership Program ajpp-online.org
Rwanda Journal of Medicine and Health Sciences (@rwandajournal) 's Twitter Profile Photo

On Friday, May 23, 2025, RJMHS Editors Prof. Stefan Jansen, MSc, PhD, Prof. Kato, & Mr. Emile met with Kirsten Bibbins -Domingo, PhD, MD, MAS, Editor-in-Chief of JAMA and the JAMA Network. The productive meeting fostered mutual exchange & explored potential collaborations.

On Friday, May 23, 2025, RJMHS Editors Prof. <a href="/stefaninkigali/">Stefan Jansen, MSc, PhD</a>, Prof. Kato, &amp; Mr. Emile met with Kirsten Bibbins -Domingo, PhD, MD, MAS, Editor-in-Chief of JAMA and the JAMA Network. The productive meeting fostered mutual exchange &amp; explored potential collaborations.
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

JAMA Oncology is now on Bluesky! 🦋 Follow us there for the latest original research, opinions, and reviews that advance the science of oncology and improve the clinical care of patients with cancer. ➡️ ja.ma/43WqKIP

JAMA Oncology is now on Bluesky! 🦋 

Follow us there for the latest original research, opinions, and reviews that advance the science of oncology and improve the clinical care of patients with cancer.

➡️  ja.ma/43WqKIP